You're reading the free version. Trader adds the live tape and alerts.
Start tracking
SYRE Sale Disclosure
Turtle Cameron · SEC Form 4 · Filed Jun 3, 2026
Sale
Calculated transaction value
$235.13K
Turtle Cameron Chief Executive Officer
SYRE
Spyre Therapeutics
SYRE
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
SYRE daily price context
Close on/before transaction
$70.54
Jun 1, 2026
First close after public filing
$78.48
Jun 4, 2026
30-day return after filing
+13.07%
Through Jul 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,294 shares @ $71.38
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001636282-26-000077
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$1.06M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 1, 2026 | $246.86K |
| Spyre Therapeutics, Inc. SYRE | Sale | Jun 1, 2026 | $574.5K |
| Spyre Therapeutics, Inc. SYRE Current | Sale | Jun 1, 2026 | $235.13K |